Skip to main content
Equibles

YI · 111, Inc. · Metrics

Track YI — free

Use YI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research YI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$3.22 -0.09 (-2.57%) At close · Oct 2
Rebalance outlook locked
Market Cap
$31.67M
Shares
8.80M
Volume · Oct 2 15.48K Avg daily vol (3M) 12.43K

YI metrics

44 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$3.22
Market cap
$31.67M

Price action

20 metrics
Price change (1W)
-10.6%
Price change (30D)
-3.3%
Price change (3M)
-22.0%
Price change (6M)
-50.0%
Price change (YTD)
+25.8%
Price change (1Y)
-30.2%
Trailing year
Price change (5Y)
-47.3%
52-week high
$8.38
52-week low
$2.56
Change from 52-week high
-61.6%
Change from 52-week low
+25.8%
Annualized volatility
90.9%
Annualized volatility (3M)
70.5%
Beta
0.5
RSI (14D)
39.3
Price vs SMA 50
-10.4%
Price vs SMA 200
-36.6%
Avg volume (3M)
12,432
Relative volume
1.2
Average dollar volume
$45,358

Company

3 metrics
Sector
Healthcare
Industry
Medical Distribution
Shares outstanding
8.80M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
—
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2024-12-31

Profitability

9 metrics
Gross margin
5.8%
Operating margin
0.0%
Trailing 12 months
Net margin
—
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
—

Growth

11 metrics
Revenue growth YoY
-12.8%
Year over year
Net income growth YoY
—
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+1.3%
Year over year · more shares
Revenue CAGR (3Y)
-2.4%
Revenue CAGR (5Y)
+8.9%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
—
Return on assets
—
Debt / equity
—
Current ratio
1.1
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
0.6
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$73.07M
Total assets
$314.63M
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
8
13F filer change QoQ
0
Institutional ownership
0.4%

Short interest

3 metrics
Short interest
0.1%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
42 / 100

Insider activity

2 metrics
Net insider buying (90D)
−$22,702
Insider-sentiment score
38 / 100

Risk flags

1 metrics
Going concern
—
Key facts CIK 1738906 CUSIP 68247Q201 Visit website Investor relations